Osmoregulation of vasopressin secretion and thirst in cyclical oedema.
Osmoregulation of vasopressin release and thirst was studied in the mid-follicular and mid-luteal phases of the menstrual cycle of five patients with cyclical oedema defined by peripheral oedema and weight gain (greater than 3.0 kg) manifest in two consecutive luteal phases. Results are compared to those already obtained in eight healthy women. In the patients, basal plasma osmolality in the mid-luteal phase was significantly lower than in the mid-follicular periods (patients, 283 +/- 1, 287 +/- 1 mOsmol/kg, respectively, mean +/- SEM, P less than 0.05; controls, 282 +/- 1, 286 +/- 1 mOsmol/kg, respectively, P less than 0.05). Plasma osmolality (pOsm) and plasma arginine vasopressin (pAVP) were measured during hypertonic (850 mmol/l) saline infusion in both phases of the cycle; linear regression analyses of these data gave the following mean regression equations, (i) mid-follicular, pAVP = 0.55 (pOsm - 285), r = 0.94 and (ii) mid-luteal, pAVP = 0.42 (pOsm - 281), r = 0.93. The abscissal intercept was significantly different (P less than 0.025). Osmotic threshold for severe thirst onset was lower in the mid-luteal phase compared to the mid-follicular value (296 +/- 1, 299 +/- 1 mOsmol/kg, respectively, P less than 0.01). Basal data and results of thirst onset and theoretical threshold for vasopressin release in response to osmotic stimulation obtained in the patients were similar to healthy control women. We conclude that osmoregulation in cyclical oedema is normal.
Thompson
C J
CJ
Endocrine Unit, Royal Victoria Infirmary, Newcastle Upon Tyne, UK.
Burd
J M
JM
Baylis
P H
PH
D000328:Adult; D001127:Arginine Vasopressin / Q000097:blood*; D001794:Blood Pressure; D004487:Edema / Q000503:physiopathology*; D005260:Female; D005498:Follicular Phase; D006801:Humans; D008183:Luteal Phase; D010507:Periodicity; D013894:Thirst / Q000502:physiology*; D014882:Water-Electrolyte Balance
D001127:Arginine Vasopressin